Ardelyx | ARDX - Current Liabilities

Stock Price
5.86
Daily Change
0.08 1.38%
Monthly
-13.31%
Yearly
8.12%
Q1 Forecast
5.61

Ardelyx reported $83.39M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Ardelyx USD 83.39M 1.67M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Curis USD 19.37M 745K Jun/2025
Sanofi EUR 28.35B 9.32B Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025
United Therapeutics USD 560.6M 14.3M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025